Xiangbei Welman Pharmaceutical Co., Ltd.

Xiangbei Welman Pharmaceutical Co., Ltd is located in Liuyang Bio- pharmaceutical Industrial Park, Hunan, China, with a registered capital of RMB 365.925 million, and covering an area of 300 acres. Welman is a major pharmaceutical company owning R&D, manufacture and trade of medicinal products with continuous innovation and R&D abilities. Welman is specialized in innovative anti-resistance and anti-superbacteria antibiotic compounded preparations, and has the largest scale in R&D, manufacturing and sales of antibiotic API / anti-resistance preparations of penicillins and cephalosporins in South China. Welman has also focused on new drug delivery routes and different areas such as psychotropic, male sexual dysfunction, gastrointestinal protection, antitumor, cardiovascular, antidepressant, Sterile Nasal Sprays, Sterile Ophthalmic Solution. The main FDFs include Ceftazidime and Avibactam Sodium for Injection, Ceftriaxone Sodium and Sulbactam Sodium for Injection, Cefotaxime Sodium and Sulbactam Sodium for Injection, Cefoperazone Sodium and Sulbactam Sodium for Injection, Piperacillin Sodium and Sulbactam Sodium for Injection, Cefotaxime Sodium and Tazobactam Sodium for Injection, Piperacillin Sodium and Tazobactam Sodium for Injection, Amoxicillin Sodium and Clavulanate Potassium for Injection, Ampicillin Sodium and Sulbactam Sodium for Injection, Amoxicillin and Clavulanate Potassium Tablet, Levofloxacin Tablet, Cefixime Capsule, Ceftriaxone Sodium for Injection, Cefotaxime Sodium for Injection etc. The main APIs include Piperacillin Sodium and Tazobactam Sodium Sterile Mixed Powder, Piperacillin Sodium, Sulbactam Sodium, Tazobactam Sodium, Tadalafil,Ruxolitinib Phosphate, Dexborneol, Butylphthalide, Ilaprazole, Avatrombopag Maleate, Icotinib Hydrochloride, Baloxavir Marboxil, Perindopril Arginine, Dosmalfate etc.